Cohu delivered a strong fourth quarter with revenue up 30% year-over-year, driven by improving market fundamentals and increased test cell utilization. The company also saw significant growth in recurring revenue.
Full year 2025 revenue reached $453.0 million, marking a 13% increase year-over-year.
Fourth quarter revenue was $122.2 million, a 30% increase compared to the same period last year.
Fourth quarter recurring revenue grew 25% year-over-year, indicating strong demand across services and solutions.
Estimated test cell utilization increased to 76% in December, supporting improved market fundamentals.
Cohu expects first quarter 2026 sales to be in the range of $122 million +/- $7 million, indicating a stable outlook.
Analyze how earnings announcements historically affect stock price performance